Life sciences companies in Cambridge no longer need to rely on London-based advisers to scale globally — the expertise exists within the region. Kim Wedral, Cambridge-based partner at law firm Winston Taylor, explains how. Cambridge has become one of Europe’s...

Clinical-stage biotech Alchemab Therapeutics has been awarded £25 million in investment from the British Business Bank. This represents the Bank’s largest investment in a life sciences company to date. Alchemab is seeking to harness the power of the immune system and cure disease...

The region claims eight spots in the country’s top 100, with six in its thriving healthcare sector. The East of England has cemented its position as one of Europe’s leading life sciences clusters, with six healthcare firms placing in the...

Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for the first time. The Cambridge-Oxford-London corridor is widely regarded as one of the most productive life...

Cambridge’s global reputation for science and technology isn’t just built on invention. Innovation is actively engineered and fine-tuned in the city - and nowhere is this more evident than the Impulse programme, the University of Cambridge’s flagship entrepreneurship initiative. Impulse curates...